{
  "drug_name": "Fondaparinux",
  "url": "https://wikem.org/wiki/Fondaparinux",
  "scraped_at": "2026-01-10T07:53:33.904707",
  "sections": {
    "Administration": {
      "text": "Type:\nAnticoagulant\nDosage Forms: Single-dose prefilled syringes of 2.5mg, 5mg, 7.5mg, and 10mg\nRoutes of Administration: Subcutaneous, IV\nCommon Trade Names: Arixtra",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Anticoagulant",
          "url": "https://wikem.org/wiki/Anticoagulant"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "STEMI, NSTEMI: 2.5mg daily\nAcute DVT, PE: 5-10mg subq daily until warfarin therapeutic\nVTE prophylaxis: 2.5mg subq daily",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Safety/efficacy not established",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing: contraindicated if CrCl <30, use with caution if CrCl 30-50\nHepatic dosing: no adjustment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nActive major bleeding\nBacterial endocarditis\nThrombocytopenia associated with antiplatelet antibody when tested with fondaparinux\nWeight <50kg\nSevere renal impairment (CrCl <30)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Bleeding, anemia, thrombocytopenia\nEpidural hematoma, spinal subdural hematoma",
          "tables": []
        },
        "Common": {
          "text": "Injection site reaction, rash\nFever",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Bleeding, anemia, thrombocytopenia\nEpidural hematoma, spinal subdural hematoma",
      "subsections": {
        "Common": {
          "text": "Injection site reaction, rash\nFever",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Injection site reaction, rash\nFever",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 17-21h\nMetabolism:\nExcretion: Renal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Inhibits antithrombin III, neutralizing Factor Xa (similar to low molecular weight heparins)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Low Molecular Weight Heparin\nAnticoagulant reversal for life-threatening bleeds",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Low Molecular Weight Heparin",
          "url": "https://wikem.org/wiki/Low_Molecular_Weight_Heparin"
        },
        {
          "text": "Anticoagulant reversal for life-threatening bleeds",
          "url": "https://wikem.org/wiki/Anticoagulant_reversal_for_life-threatening_bleeds"
        }
      ]
    }
  }
}